ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,999.30
0.00%
S&P ASX All Technology
3,160.00
0.00%
Brent Oil
83.315
-1.22%
US Dollar vs AUD
1.48525
0.45%
Bitcoin
64,779.28
-0.11%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oramed Pharmaceuticals Inc (ORMP)

  7. Oramed Pharmaceuticals Inc (ORMP) News

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
03/09/200923:15PR Newswire (US)Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare ConferenceNASDAQ:ORMP
25/08/200923:15PR Newswire (US)Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation AwardNASDAQ:ORMP
18/08/200923:15PR Newswire (US)Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in MancNASDAQ:ORMP
04/08/200922:45PR Newswire (US)Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief ScientistNASDAQ:ORMP
21/07/200921:00PR Newswire (US)Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic PatientsNASDAQ:ORMP
10/06/200921:09PR Newswire (US)Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009NASDAQ:ORMP
05/05/200921:20PR Newswire (US)Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin CapsuleNASDAQ:ORMP
25/03/200923:40PR Newswire (US)Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New ONASDAQ:ORMP
04/02/200923:30PR Newswire (US)Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin SuppositoryNASDAQ:ORMP
15/11/200800:00PR Newswire (US)Oramed Pharmaceuticals Presents Results of Oral Administration of Exenatide-4; Proof of Concept Pharmacodynamic Study in DogsNASDAQ:ORMP
04/11/200823:00PR Newswire (US)Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology SocietyNASDAQ:ORMP
30/10/200822:00PR Newswire (US)Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)NASDAQ:ORMP
24/10/200800:40PR Newswire (US)Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin SuppositoryNASDAQ:ORMP
23/10/200823:32PR Newswire (US)/K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./NASDAQ:ORMP
23/10/200823:30PR Newswire (US)Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin SuppositoryNASDAQ:ORMP
24/09/200821:30PR Newswire (US)Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 DiabeticsNASDAQ:ORMP
16/09/200822:00PR Newswire (US)Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery PlatformNASDAQ:ORMP
09/09/200821:30PR Newswire (US)Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801NASDAQ:ORMP
18/08/200821:30PR Newswire (US)Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)NASDAQ:ORMP
07/08/200801:30PR Newswire (US)Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin CapsuleNASDAQ:ORMP
31/07/200821:30PR Newswire (US)Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical TrialsNASDAQ:ORMP
28/07/200821:30PR Newswire (US)Oramed Pharmaceuticals Appoints Dr. Harold Jacob to its Board of DirectorsNASDAQ:ORMP
15/07/200821:30PR Newswire (US)Oramed Pharmaceuticals Raises $5 Million Through a Private PlacementNASDAQ:ORMP
10/07/200822:00PR Newswire (US)Nobel Prize Winner Professor Avram Hershko Named to Oramed Pharmaceuticals Scientific Advisory BoardNASDAQ:ORMP
04/06/200822:45PR Newswire (US)Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)NASDAQ:ORMP
06/05/200819:00PR Newswire (US)Israel's Prestigious President's Conference to Feature Oramed Pharmaceuticals' Revolutionary Oral Insulin CapsuleNASDAQ:ORMP
14/08/200722:47PR Newswire (US)Oramed Pharmaceuticals Successfully Completes Phase 1A TrialsNASDAQ:ORMP
07/08/200700:00PR Newswire (US)Oramed Pharmaceuticals Completes $2 Million in FinancingNASDAQ:ORMP
19/06/200723:47PR Newswire (US)Oramed Pharmaceuticals Signs Agreement with Encorium Group to Commence Investigational New Drug ApplicationNASDAQ:ORMP
06/06/200723:47PR Newswire (US)Exclusive Interview with Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.CEOcast.comNASDAQ:ORMP
 Showing the most relevant articles for your search:NASDAQ:ORMP

Your Recent History

BOV
EZTC3R
EZTEC ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved